Literature DB >> 6781554

Altered expression of histocompatibility antigens on "B" large cell lymphomas.

B A Woda, B Racklin, H Rappaport.   

Abstract

We describe three malignant lymphomas of the diffuse "histiocytic" (large noncleaved) type in which most of the large lymphoid cells express monoclonal surface immunoglobulin and HLA-DR antigens but do not express HLA-A,B,C, or beta-2-microglobulin as assessed by indirect immunofluorescence.

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 6781554

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


  5 in total

1.  Maturation of human B lymphocytes--studies with a panel of monoclonal antibodies against membrane antigens.

Authors:  H Zola; P J McNamara; H A Moore; I J Smart; D A Brooks; I G Beckman; J Bradley
Journal:  Clin Exp Immunol       Date:  1983-06       Impact factor: 4.330

2.  The immunologic characterization of 95 nodal and extranodal diffuse large cell lymphomas in 89 patients.

Authors:  R S Doggett; G S Wood; S Horning; R Levy; R F Dorfman; J Bindl; R A Warnke
Journal:  Am J Pathol       Date:  1984-05       Impact factor: 4.307

3.  Major histocompatibility complex class I and class II antigen expression in diffuse large cell and large cell immunoblastic lymphomas. Absence of a correlation between antigen expression and clinical outcome.

Authors:  L J Medeiros; A B Gelb; K Wolfson; R Doggett; B McGregor; R S Cox; S J Horning; R A Warnke
Journal:  Am J Pathol       Date:  1993-10       Impact factor: 4.307

4.  The primary mediastinal clear cell lymphoma of B-cell type has variable defects in MHC antigen expression.

Authors:  P Möller; B Lämmler; B Herrmann; H F Otto; G Moldenhauer; F Momburg
Journal:  Immunology       Date:  1986-11       Impact factor: 7.397

5.  Association of HLA alleles with non-Hodgkin's lymphoma in Korean population.

Authors:  Hee-Baeg Choi; Sang-Young Roh; Eun-Jung Choi; Ho-Yeul Yoon; Su-Yeon Kim; Young-Sun Hong; Dong-Wook Kim; Tai-Gyu Kim
Journal:  Int J Hematol       Date:  2008-02-27       Impact factor: 2.490
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.